Showing results (1881-1890 of 1,906) with videos related to
Sort By:
Pageof 191
JAMA|December 13, 2024
Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer: The CamRelief Randomized Clinical TrialLi Chen, Hui Li, Hao Zhang, et al.American Heart Journal|February 23, 2021
Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome: rationale and design of prospective, multicenter, randomized, controlled IVUS-ACS and ULTIMATE-DAPT trialZhen Ge, Xiao-Fei Gao, Jing Kan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II TrialLi Chen, Yi-Zhou Jiang, Song-Yang Wu, et al.The Lancet. Gastroenterology & Hepatology|March 17, 2023
Machine learning-based automated sponge cytology for screening of oesophageal squamous cell carcinoma and adenocarcinoma of the oesophagogastric junction: a nationwide, multicohort, prospective studyYe Gao, Lei Xin, Han Lin, et al.ACS Medicinal Chemistry Letters|April 15, 2026
DNA-Encoded Library (DEL) Selection Identifies a Distinct DDB1 Ligand Binding SiteShiva Krishna Reddy Guduru, John P Caldwell, Katherine M Digianantonio, et al.Journal of Hepatology|June 11, 2023
Novel, high accuracy models for hepatocellular carcinoma prediction based on longitudinal data and cell-free DNA signaturesRong Fan, Lei Chen, Siru Zhao, et al.Nature Genetics|November 24, 2020
Common variants in signaling transcription-factor-binding sites drive phenotypic variability in red blood cell traitsAvik Choudhuri, Eirini Trompouki, Brian J Abraham, et al.Molecular Cell|April 9, 2016
Stress from Nucleotide Depletion Activates the Transcriptional Regulator HEXIM1 to Suppress MelanomaJustin L Tan, Rachel D Fogley, Ryan A Flynn, et al.Developmental Cell|April 29, 2023
Transcription factor induction of vascular blood stem cell niches in vivoElliott J Hagedorn, Julie R Perlin, Rebecca J Freeman, et al.Proceedings of the National Academy of Sciences of the United States of America|September 5, 2020
CHD7 and Runx1 interaction provides a braking mechanism for hematopoietic differentiationJingmei Hsu, Hsuan-Ting Huang, Chung-Tsai Lee, et al.Pageof 191